Biologically synthesized green gold nanoparticles from Siberian ginseng induce growth-inhibitory effect on melanoma cells (B16)

References

• Armendariz V, Herrera I, peralta-videa JR, et al. Size controlled gold nanoparticle formation by Avena sativa biomass. J. Nanoparticle Res. 2004;6:377–382.
   Web of Science ®Google Scholar
• Castelvetro V, De Vita C. Nanostructured hybrid materials from aqueous polymer dispersions. Adv Colloid Interface Sci. 2004;108–109:167–185.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials. 2005;26:3995–4201.
   PubMed Web of Science ®Google Scholar
• Raut R,W, Niranjan Kolekar S, Jaya Lakkakula R, Vijay Mendhulkar D, Sahebrao Kashid B. Extracellular synthesis of silver nanoparticles using dried leaves of pongamia pinnata (L) pierre. Nano-Micro Lett. 2010;2:106–113.
   Web of Science ®Google Scholar
• Selvi VK, Sivakumar T. Antihelminthic, anticancer, antioxidant activity of silver nanoparticles isolated from f.oxysporum. Int J Cur Res Chem Pharm Sci. 2014;1:105–111.
   Google Scholar
• Priyaragini S, Sathishkumar SR, Bhaskararao KV. Biosynthesis of silver nanoparticles using actinobacteria and evaluating its antimicrobial and cytotoxicity activity. Int J Pharm Pharm Sci 2013;2:709–712.
   Google Scholar
• Singh M, Kalaivani R, Manikandan S, et al. Facile green synthesis of variable metallic gold nanoparticle using Padina gymnospora, a brown marine macroalga. Appl Nanosci. 2013;3:145–151.
   Web of Science ®Google Scholar
• Gao D. Drug designing: open access drug design for cancer: gold nanoparticle-liposome hybrids for drug delivery and monitoring. Drug Des. 2013;2:10–11.
   Google Scholar
• Engin AB, Nikitovic D, Neagu M, et al. Mechanistic understanding of nanoparticles? Interactions with extracellular matrix: the cell and immune system. Part Fibre Toxicol 2017;14:22.
   PubMed Web of Science ®Google Scholar
• Wu CC, Chen DH. Facile green synthesis of gold nanoparticles with gum arabic as a stabilizing agent and reducing agent. Gold Bull. 2010;43:234–239.
   Web of Science ®Google Scholar
• Garrido C, Simpson CA, Dahl NP, et al. Gold nanoparticles to improve HIV drug delivery. Future Med Chem. 2015;7:1097–1107.
   PubMed Web of Science ®Google Scholar
• Khan A, Rashid R, Murtaza G, et al. Gold nanoparticles: synthesis and applications in drug delivery. Trop J Pharm Res. 2014;13:1169–1177.
   Web of Science ®Google Scholar
• Tiwari PM, Vig K, Dennis VA, et al. Functionalized gold nanoparticles and their biomedical applications. Nanomaterials 2011;1:31–63.
   Web of Science ®Google Scholar
• Pedrosa P, Vinhas R, Fernandes A, et al. Gold nanotheranostics: proof-of-concept or clinical tool? Nanomaterials (Basel). 2015;5:1853–1879.
   PubMedGoogle Scholar
• Akihisa T, Tokuda H, Hasegawa D, et al. Enjo, F: Chalcones and other compounds from the exudates of Angelica keiskei and their cancer chemnopreventive effects. J Nat Prod. 2006;69:38–42.
   PubMed Web of Science ®Google Scholar
• Enoki T, Ohnogi H, Nagamine K, et al. Antidiabetic activities of chalcones isolated from a Japanese Herb, Angelica keiskei. J Agric Food Chem. 2007;55:6013–6017.
   PubMed Web of Science ®Google Scholar
• Kimura Y, Baba K. Antitumor and antimetastatic activities of Angelica keiskei roots, part 1: Isolation of an active substance, xanthoangelol. Int J Cancer. 2003;106:429–437.
   PubMed Web of Science ®Google Scholar
• Caesar LK, Cech NB. A Review of the Medicinal Uses and Pharmacology of Ashitaba. Planta Med. 2016;82:1236–1245.
   PubMed Web of Science ®Google Scholar
• Okuyama T, Takata M, Takayasu J, et al. Anti-tumor-promotion by principles obtained from Angelica keiskei . Planta Med. 1991;57:242–246.
   PubMed Web of Science ®Google Scholar
• Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156–159.
   PubMed Web of Science ®Google Scholar
• Chanda N, Kan P, Watkinson LD, et al. Radioactive gold nanoparticles in cancer therapy: therapeutic efficacy studies of GA-198AuNP nanoconstruct in prostate tumor-bearing mice. Nanomedicine. 2010;6:201–209.
   PubMed Web of Science ®Google Scholar
• Dhar S, Reddy EM, Shiras A, et al. Natural gum reduced/stabilized gold nanoparticles for drug delivery formulations. Chemistry. 2008;14:10244–10250.
   PubMed Web of Science ®Google Scholar
• Venkatesan J, Manivasagan P, Kim SK, et al. Marine algae-mediated synthesis of gold nanoparticles using a novel Ecklonia cava. Bioprocess Biosyst Eng. 2014;37:1591–1597.
   PubMed Web of Science ®Google Scholar
• Mie G. Beiträge zur Optik trüber Medien, speziell kolloidaler Metallösungen. Ann Phys. 1908;25:377.
   Google Scholar
• Saxena A, Tripathi RM, Singh P. Biological Synthesis of silver nanoparticles by using onion (Allium cepa) extract and their antibacterial activity. Digest J Nanomater Biostruct. 2010;5:427–432.
   Web of Science ®Google Scholar
• Ghodake G, Lee DS. Biological synthesis of gold nanoparticles using the aqueous extract of the brown algae Laminaria japonica. J. Nanoelectron Optoe 2011;6:1–4.
   Web of Science ®Google Scholar
• Jiang BP, Zhang L, Guo XL, et al. Poly(N-phenylglycine)-based nanoparticles as highly effective and targeted near-infrared photothermal therapy/photodynamic therapeutic agents for malignant melanoma. Small 2017;13:1602496
   Web of Science ®Google Scholar
• Bombelli FB, Webster CA, Moncrieff M, et al. The scope of nanoparticle therapies for future metastatic melanoma treatment. Lancet Oncol. 2014;15:e22–32.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–86.
   PubMed Web of Science ®Google Scholar
• Domingues B, Lopes JM, Soares P, et al. Melanoma treatment in review. Immunotargets Ther. 2018;7:35–49.
   PubMed Web of Science ®Google Scholar
• Wong RS. Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res. 2011;30:87.
   PubMed Web of Science ®Google Scholar
• Kumar V, Abbas AK, Fausto N, et al. Robins and Cotran: pathologic basis of disease. Vol. 8. Philadelphia: Saunders Elsevier; 2010. p. 25–32.
   Google Scholar
• Hassan M, Watari H, AbuAlmaaty A, et al. Apoptosis and molecular targeting therapy in cancer. Biomed Res Int. 2014;2014:1.
   Web of Science ®Google Scholar
• Koff JL, Ramachandiran S, Bernal-Mizrachi L. A time to kill: targeting apoptosis in cancer. Int J Mol Sci. 2015;16:2942–2955.
   PubMed Web of Science ®Google Scholar
• Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell. 2004;23:205–219.
   Web of Science ®Google Scholar
• Abou-Nassar K, Brown JR. Novel agents for the treatment of chronic lymphocytic leukaemia. Clin Adv Haematol Oncol 2010;8:886–895.
   PubMedGoogle Scholar
• Oltersdorf T, Elmore SW, Shoemaker AR, et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature. 2005;2:677–681.
   Web of Science ®Google Scholar
• Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev. 2007;87:99–163.
   PubMed Web of Science ®Google Scholar